Cargando…
Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS)
Polyhedral oligomeric silsesquioxane (POSS), bearing eight 3-chloroammoniumpropyl substituents, was studied as a potential nanocarrier in co-delivery systems with doxorubicin (DOX). The toxicity of doxorubicin and POSS:DOX complexes at four different molar ratios (1:1; 1:2, 1:4, 1:8) towards microva...
Autores principales: | Sobierajska, Ewelina, Konopka, Malgorzata, Janaszewska, Anna, Piorecka, Kinga, Blauz, Andrzej, Klajnert-Maculewicz, Barbara, Stanczyk, Maciej, Stanczyk, Wlodzimierz A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459003/ https://www.ncbi.nlm.nih.gov/pubmed/28772919 http://dx.doi.org/10.3390/ma10050559 |
Ejemplares similares
-
Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)(32), as a Complexing Nanocarrier for Doxorubicin and Daunorubicin
por: Piorecka, Kinga, et al.
Publicado: (2020) -
In Vitro Studies of Polyhedral Oligo Silsesquioxanes: Evidence for Their Low Cytotoxicity
por: Janaszewska, Anna, et al.
Publicado: (2015) -
Novel Polyhedral Silsesquioxanes [POSS(OH)(32)] as Anthracycline Nanocarriers—Potential Anticancer Prodrugs
por: Piorecka, Kinga, et al.
Publicado: (2020) -
Polybenzoxazine/Polyhedral Oligomeric Silsesquioxane (POSS) Nanocomposites
por: Mohamed, Mohamed Gamal, et al.
Publicado: (2016) -
Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy
por: Marcinkowska, Monika, et al.
Publicado: (2018)